The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
Yang Woon Lee, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Dae Bum Kim, Yeon Ji Kim, Woo Chul Chung, Chang-Nyol Paik
Korean J Intern Med. 2019;34(1):72-80. Published online 2018 Jan 20 DOI: https://doi.org/10.3904/kjim.2016.324
Citations to this article as recorded by 
Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease
Akihiko Oka, Kousaku Kawashima, Kenichi Kishimoto, Satoshi Kotani, Mai Fukunaga, Nobuhiko Fukuba, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Muyiwa Awoniyi, Shunji Ishihara
Scientific Reports.2024;[Epub] CrossRef
Fecal calprotectin is a novel biomarker to predict the clinical outcomes of patients with ruptured intracranial aneurysm
Jun-da Shen, Bin Yuan, An Zhang, Xiao-Ming Zhou, Shu-Juan Chen, Jin-Long Deng, Xin Zhang, Hai-Yang Jiang, Qing Yu, Qi Wu
Journal of Stroke and Cerebrovascular Diseases.2024; : 107634. CrossRef
(Re)Appraising Remission in Ulcerative Colitis
Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein, David T Rubin
Inflammatory Bowel Diseases.2023; 29(8): 1317. CrossRef
Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease
Junrong Li, Mingyang Xu, Wei Qian, Fangmei Ling, Yidong Chen, Shuang Li, Yiyu Cheng, Liangru Zhu
Frontiers in Physiology.2023;[Epub] CrossRef
Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions
Joseph William Clinton, Raymond Keith Cross
Clinical and Experimental Gastroenterology.2023; Volume 16: 249. CrossRef
Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis
Saranya Sasidharan, Alexa N Sasson, Kevin M Shannon, Ashwin N Ananthakrishnan
Inflammatory Bowel Diseases.2022; 28(12): 1833. CrossRef
Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial
Hyeong Ho Jo, Eun Young Kim, Jin Tae Jung, Joong Goo Kwon, Eun Soo Kim, Hyun Seok Lee, Yoo Jin Lee, Kyeong Ok Kim, Byung Ik Jang
Clinical Endoscopy.2022; 55(2): 256. CrossRef
Serum Calprotectin as a Blood-Based Biomarker for Monitoring Knee Osteoarthritis at Early but Not Late Stages
Amin Safa, Abolfazl Bagherifard, Hamadalla Hadi Al-Baseesee, Azade Amini Kadijani, Hooman Yahyazadeh, Masoumeh Azizi, Abolfazl Akbari, Alireza Mirzaei
CARTILAGE.2021; 13(1_suppl): 1566S. CrossRef
Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort
A. Al Khoury, Y. Xiao, P.A. Golovics, R. Kohen, W. Afif, G. Wild, G. Friedman, P. Galiatsatos, N. Hilzenrat, A. Szilagyi, J. Wyse, A. Cohen, A. Bitton, T. Bessissow, P.L. Lakatos
Digestive and Liver Disease.2021; 53(8): 980. CrossRef
Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review
Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu
World Journal of Gastroenterology.2021; 27(16): 1828. CrossRef
Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński, Małgorzata Krzystek-Korpacka
Journal of Clinical Medicine.2021; 10(10): 2203. CrossRef
Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
Erin Crawford, Catherine Gestrich, Sindhoosha Malay, Denise Young, Sharon Perry, Judy Splawski, Thomas J. Sferra, Shahrazad Saab, Jonathan Moses
JPGN Reports.2021; 2(4): e129. CrossRef
Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Bing-Jie Xiang, Min Jiang, Ming-Jun Sun, Cong Dai
Visceral Medicine.2021; 37(5): 338. CrossRef
Fecal Calprotectin Is Increased in Stroke
Shin Young Park, Sang Pyung Lee, Woo Jin Kim
Journal of Clinical Medicine.2021; 11(1): 159. CrossRef
ROLE OF FECAL CALPROTECTIN IN DIFFERENTIATION OF INFLAMMATORY BOWEL DISEASES IN PATIENTS COMPLAINING OF ABDOMINAL SYMPTOMS AND REFERRED FOR COLONOSCOPY
Trifa Mahmood, Mohammed Mohammed, Dana Gharib, Taha Mohamad, Muhsin Mohammed, Araz Rahim
JOURNAL OF SULAIMANI MEDICAL COLLEGE.2021; 11(1): 33. CrossRef
Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis
Fangze Zhang, Cuili Ma, Bin Zhang, Liqi Bi
Clinical Rheumatology.2020; 39(9): 2653. CrossRef
Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer
Diagnostics.2020; 10(6): 367. CrossRef
Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa
European Journal of Gastroenterology & Hepatology.2020; 32(9): 1091. CrossRef
Age-Related Fecal Calprotectin Concentrations in Healthy Adults
Shin Young Park
The Korean Journal of Clinical Laboratory Science.2020; 52(3): 181. CrossRef
Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores
Bruno Lima Rodrigues, Márcia Carolina Mazzaro, Cristiane Kibune Nagasako, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal
World Journal of Gastrointestinal Endoscopy.2020; 12(12): 504. CrossRef
Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we
stand in Korea?
Jae Myung Cha
The Korean Journal of Internal Medicine.2019; 34(1): 60. CrossRef
From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa
World Journal of Gastroenterology.2018; 24(33): 3681. CrossRef
Recent advances in ankylosing spondylitis: understanding the disease and management
Leticia Garcia-Montoya, Hanna Gul, Paul Emery
F1000Research.2018; 7: 1512. CrossRef